First ever case of intermittent blindness reported

Article

A young woman is suffering from a condition that leaves her blind, but only for half the time. For the last four years, Natalie Adler's eyes have regularly clamped shut for three days every week, and then reopened for the next three days.

An Australian Professor has reported, what he believes to be the first ever case of an intermittently blinding condition. His patient is a young woman who is suffering from a condition that leaves her blind, but only for half the time. For the last four years, Natalie Adler's eyes have regularly clamped shut for three days every week, and then reopened for the next three days.

Professor Justin O'Day, head of neuro-ophthalmology at the Royal Eye and Ear Hospital in Melbourne, Australia has been unable to establish a definitive diagnosis, but believes Ms Adler may be affected by a form of blepharospasm. She appears to be the only person in the world suffering from this condition.

Ms Adler first suffered from swollen eyes four years ago, due to what her doctors believed was a staph and sinus infection. The closing of her eyes was at first intermittent, although the regular cycle of opening and closing was established within weeks. On days when her eyes are closed, Ms Adler is left with a small open slit in her left eye; the rest of the time, her eyes function normally although her left eyelid occasionally droops.

Although conceding that the regularity of the condition and the age of the patient make blepharospasm an unlikely diagnosis, Professor O'Day was unable to offer an alternative diagnosis.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.